Comparison
N-Acetyl Cysteine vs Tirzepatide
Side-by-side of N-Acetyl Cysteine and Tirzepatide. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
N-Acetyl Cysteine
NAC supplement benefits cover glutathione synthesis, liver and antioxidant support, and hangover recovery. Evidence strongest at 1200-2400 mg/day.
Tirzepatide
Tirzepatide for weight loss: dual GIP/GLP-1 agonist sold as Mounjaro and Zepbound. SURMOUNT-1 showed 22.5% mean body-weight loss at 15 mg over 72 weeks.
Effects at a glance
N-Acetyl Cysteine
- •Replenishes intracellular glutathione by supplying cysteine, the rate-limiting amino acid for synthesis
- •First-line antidote for acetaminophen toxicity, restoring hepatic glutathione before fulminant injury occurs
- •Reduces sputum viscosity in chronic bronchitis and COPD at 600 to 1200 mg/day over months
- •Modest symptom reductions in OCD and trichotillomania at 1200 to 2400 mg/day across small RCTs
- •Mixed evidence for psychiatric adjunct use in bipolar depression and schizophrenia negative symptoms
- •Inhaled forms can trigger bronchospasm in active asthma; oral use is the standard biohacker route
Tirzepatide
- •Dual GIP plus GLP-1 receptor agonist with a ~5-day half-life supporting once-weekly subcutaneous dosing
- •SURMOUNT-1 reported ~22.5% mean body-weight loss at 15 mg over 72 weeks versus 2.4% on placebo
- •Lowers HbA1c by ~1.9 to 2.6 percentage points in type 2 diabetes across SURPASS trials
- •Outperformed semaglutide 1.0 mg head-to-head on weight loss and HbA1c in SURPASS-2
- •GI effects (nausea, diarrhea, vomiting) drive most discontinuations and ease with slow titration
- •Lean-mass loss observed in body-composition substudies; resistance training and protein intake mitigate this
Side-by-side
| Attribute | N-Acetyl Cysteine | Tirzepatide |
|---|---|---|
| Category | supplement | pharmaceutical |
| Also known as | NAC | Mounjaro, Zepbound, LY3298176 |
| Half-life (hr) ↗ | 5.6 | 120 |
| Typical dose (mg) ↗ | 1200 | 10 |
| Dosing frequency | 1 to 3 times daily, split dosing preferred | weekly |
| Routes | oral, iv | subcutaneous |
| Onset (hr) | 1 | 24 |
| Peak (hr) | 2 | 72 |
| Molecular weight | 163.19 | 4813.45 |
| Molecular formula | C5H9NO3S | C225H348N48O68 |
| Mechanism | Deacetylated to cysteine, the rate-limiting precursor for glutathione synthesis; also directly scavenges reactive oxygen species and modulates glutamate signaling. | Synthetic 39-amino-acid peptide that activates both GIP and GLP-1 receptors. Potentiates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and acts on hypothalamic and brainstem satiety circuits. |
| Legal status | OTC in most jurisdictions; restricted periods in US history (FDA reclassified 2022) | Prescription only; FDA-approved 2022 (T2DM, Mounjaro) and 2023 (chronic weight management, Zepbound) |
| WADA status | allowed | allowed |
| DEA / Rx | OTC supplement (US, post-2022); Rx indications also exist (acetaminophen overdose, mucolytic) | Rx only (not a controlled substance) |
| Pregnancy | Used clinically in pregnancy for specific indications; consult clinician | Not recommended; discontinue 2 months before planned pregnancy |
| CAS | 616-91-1 | 2023788-19-2 |
| PubChem CID | 12035 | 156588324 |
| Wikidata | Q413299 | Q105099794 |
Safety profile
N-Acetyl Cysteine
Common side effects
- sulfur-like taste or odor
- nausea
- flatulence
- diarrhea
Contraindications
- active asthma attack (inhaled form can trigger bronchospasm)
- known NAC hypersensitivity
Interactions
- nitroglycerin: potentiates vasodilation, risk of hypotension and headache(moderate)
- activated charcoal: reduces NAC absorption when used for acetaminophen overdose(moderate)
- anticoagulants: theoretical additive antiplatelet effect at high doses(minor)
Tirzepatide
Common side effects
- nausea
- diarrhea
- vomiting
- constipation
- decreased appetite
- injection-site reactions
- fatigue
- abdominal pain
Contraindications
- personal or family history of medullary thyroid carcinoma
- multiple endocrine neoplasia type 2
- pregnancy
- history of pancreatitis (use caution)
- severe gastroparesis
Interactions
- insulin: additive hypoglycemia risk; insulin dose typically reduced(major)
- sulfonylureas (glipizide, glyburide): hypoglycemia risk, sulfonylurea dose often reduced(major)
- oral medications (general): delayed gastric emptying can alter absorption kinetics(moderate)
- oral contraceptives: reduced exposure after first dose; backup contraception recommended for 4 weeks after initiation and each dose escalation(moderate)
- warfarin: monitor INR due to altered absorption(moderate)
Which Should You Take?
N-Acetyl Cysteine comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC, oral dosing, with a Tier-A outcome catalogued. Tirzepatide is the right call when one of the conditionals below applies.
- → If your priority is healthspan extension, pick N-Acetyl Cysteine.
- → If your priority is post-training recovery, pick N-Acetyl Cysteine.
- → If your priority is metabolic health and glucose control, pick Tirzepatide.
- → If your priority is fat loss, pick Tirzepatide.
Edge case: If you want to avoid prescription-only, N-Acetyl Cysteine is the more accessible choice.
Default choice: N-Acetyl Cysteine. Wider use case, a Tier-A evidence outcome catalogued, and broader goal coverage. Reach for Tirzepatide only if your priority sits squarely in the goals it owns above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between N-Acetyl Cysteine and Tirzepatide?
N-Acetyl Cysteine and Tirzepatide differ in category (supplement vs pharmaceutical), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, N-Acetyl Cysteine or Tirzepatide?
N-Acetyl Cysteine half-life is 5.6 hours; Tirzepatide half-life is 120 hours.
Can you stack N-Acetyl Cysteine with Tirzepatide?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper